Pediatric Asthma and the Indoor Microbial Environment

Lidia Casas1,2,3,4, Christina Tischer5,6,7, Martin Täubel8

  • 1Department of Public Health and Primary Care, Centre for Environment and Health, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. lidia.casasruiz@kuleuven.be.

Insights

Exposure to indoor microbes, especially in early life, influences asthma development. While moisture damage may worsen asthma, diverse microbial environments, like farms, might protect, though research methods need improvement.

Area of Science:

  • Environmental Health
  • Microbiology
  • Epidemiology

Background:

  • Global asthma prevalence is increasing, linked to 'westernization' and indoor microbial exposures during early life.
  • Moisture-damaged homes are associated with asthma exacerbation and development.
  • Exposure to diverse microbes in environments like traditional farms may offer protective effects against asthma.

Purpose of the Study:

  • To explore the inconsistent associations between indoor microbial exposure and asthma.
  • To highlight the limitations of current sampling and measurement techniques for indoor microbial environments.
  • To emphasize the potential of new generation sequencing for understanding the indoor microbiome's impact on health.

Main Methods:

  • Review of existing research on indoor moisture, microbial environments (farming vs. non-farming), and asthma.
  • Analysis of limitations in current sampling and measurement techniques for indoor microbial exposure.
  • Consideration of advanced techniques like new generation sequencing.

Main Results:

  • Consistent findings exist for indoor moisture damage and farming vs. non-farming comparisons.
  • Associations become inconsistent when actual indoor microbial exposure measures are included.
  • Current methods provide an incomplete picture of the indoor microbiome and human exposure.

Conclusions:

  • Understanding the indoor microbiome's role in asthma requires improved measurement techniques.
  • New generation sequencing offers a promising approach to accurately assess indoor microbial exposure and its health impacts.
  • Further research is needed to clarify the relationship between indoor microbial diversity and asthma development.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
1
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K